Biotage AB Performance
| BITGFDelisted Stock | USD 15.01 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biotage AB are expected to decrease at a much lower rate. During the bear market, Biotage AB is likely to outperform the market. Biotage AB right now shows a risk of 0.0%. Please confirm Biotage AB maximum drawdown, as well as the relationship between the kurtosis and day typical price , to decide if Biotage AB will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Biotage AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Biotage AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 371.3 M | |
| Total Cashflows From Investing Activities | -341 M |
Biotage |
Biotage AB Relative Risk vs. Return Landscape
If you would invest 1,501 in Biotage AB on September 29, 2025 and sell it today you would earn a total of 0.00 from holding Biotage AB or generate 0.0% return on investment over 90 days. Biotage AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Biotage, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Biotage AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotage AB's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Biotage AB, and traders can use it to determine the average amount a Biotage AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BITGF |
Based on monthly moving average Biotage AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotage AB by adding Biotage AB to a well-diversified portfolio.
Biotage AB Fundamentals Growth
Biotage OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Biotage AB, and Biotage AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotage OTC Stock performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Current Valuation | 1.17 B | |||
| Shares Outstanding | 65.98 M | |||
| Price To Earning | 47.58 X | |||
| Price To Book | 6.36 X | |||
| Price To Sales | 6.61 X | |||
| Revenue | 1.23 B | |||
| EBITDA | 347 M | |||
| Cash And Equivalents | 15.1 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 150 M | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | 353 M | |||
| Earnings Per Share | 0.35 X | |||
| Total Asset | 1.99 B | |||
| Retained Earnings | 541 M | |||
| Current Asset | 327 M | |||
| Current Liabilities | 115 M | |||
About Biotage AB Performance
By analyzing Biotage AB's fundamental ratios, stakeholders can gain valuable insights into Biotage AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biotage AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotage AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States.Things to note about Biotage AB performance evaluation
Checking the ongoing alerts about Biotage AB for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Biotage AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotage AB is not yet fully synchronised with the market data | |
| Biotage AB has a very high chance of going through financial distress in the upcoming years | |
| About 65.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Biotage AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotage AB's stock is overvalued or undervalued compared to its peers.
- Examining Biotage AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotage AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotage AB's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Biotage AB's otc stock. These opinions can provide insight into Biotage AB's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Biotage OTC Stock
If you are still planning to invest in Biotage AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotage AB's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |